SCHEMBL4630263

SCHEMBL4630263

CCCCCCc1cccc(-c2ccccc2)c1[O]

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.50
NR1H3 Q13133 1/20 0.50
PPARA Q07869 4/20 0.48
BID P55957 3/20 0.48
MCL1 Q07820 3/20 0.48
BCL2L1 Q07817 2/20 0.48
BAK1 Q16611 2/20 0.48
KAT8 Q9H7Z6 2/20 0.48
PPARG P37231 2/20 0.48
EP300 Q09472 1/20 0.48
KAT2A Q92830 1/20 0.48
KAT2B Q92831 1/20 0.48
KAT5 Q92993 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
LIPG Q9Y5X9 1/20 0.47
SOAT1 P35610 2/20 0.44
CYSLTR2 Q9NS75 4/20 0.43
CYSLTR1 Q9Y271 4/20 0.43
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630157 0.98 NR1H2 (0.48) NR1H2NR1H3PPARABIDMCL1
SCHEMBL4630656 0.93 PDCD1 (0.43) NR1H2NR1H3PPARABIDMCL1
SCHEMBL3563200 0.86 PDCD1 (0.46) PPARASOAT1PTPN1
SCHEMBL2303757 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL760598 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL761403 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL30631255 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL251097 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL8521601 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1
SCHEMBL3726514 0.84 LIPG (0.55) NR1H2NR1H3PPARABIDMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed